Our findings demonstrating low expression of NOTCH receptors, ADAM17, γ-secretase, and NOTCH target genes in MYCN-amplified tumors, suggest that MYCN amplification contributes to the down-regulation of genes related to the NOTCH pathway in NB. Here, MYCN is linked to neuroblastoma.